![David M. Fineman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David M. Fineman
Director Ejecutivo en
KINEMED INC
.
Perfil
David M.
Fineman is the founder of KineMed, Inc. (founded in 2001) where he currently serves as the Chairman & Chief Executive Officer.
He was also the founder of Quark Pharmaceuticals, Inc. (founded in 1993) where he served as a Director.
Dr. Fineman's former job includes being the Acting Chief Financial Officer at SuperGen, Inc. (1990-2013).
Dr. Fineman's education history includes an undergraduate degree from the University of Maryland (conferred in 1966) and a graduate degree from The New School for Social Research.
Cargos activos de David M. Fineman
| Empresas | Cargo | Inicio |
|---|---|---|
| KINEMED INC | Director Ejecutivo | 29/08/2013 |
Antiguos cargos conocidos de David M. Fineman.
| Empresas | Cargo | Fin |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Fundador | - |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Director Financiero/CFO | - |
Formación de David M. Fineman.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
60
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs, diagnostics and other therapeutic products | Health Technology |
KineMed, Inc.
 KineMed, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biomarker platform technology | Commercial Services |
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops novel RNAi-based therapeutics | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The New School for Social Research
 The New School for Social Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- David M. Fineman
